These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23274577)

  • 21. Effect of angiotensin converting enzyme inhibitors on periprocedural myocardial infarction in patients with metabolic syndrome.
    Ozcan OU; Ustun EE; Gulec S; Gerede DM; Goksuluk H; Vurgun VK; Kaya CT; Erol C
    Cardiol J; 2015; 22(3):323-9. PubMed ID: 25563711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
    J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization.
    Verdoia M; Barbieri L; Schaffer A; Cassetti E; Marino P; Bellomo G; Sinigaglia F; De Luca G;
    Heart Vessels; 2015 Jan; 30(1):20-7. PubMed ID: 24297745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
    Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective role of chronic statin therapy in reducing myocardial damage during percutaneous coronary intervention.
    Auguadro C; Manfredi M; Scalise F; Mortara A; Specchia G
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):416-21. PubMed ID: 16721204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
    Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colocalization of thin-cap fibroatheroma and spotty calcification is a powerful predictor of procedure-related myocardial injury after elective coronary stent implantation.
    Ueda T; Uemura S; Watanabe M; Sugawara Y; Soeda T; Okayama S; Takeda Y; Kawata H; Kawakami R; Saito Y
    Coron Artery Dis; 2014 Aug; 25(5):384-91. PubMed ID: 24681754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long-Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry.
    Inohara T; Kohsaka S; Miyata H; Sawano M; Ueda I; Maekawa Y; Fukuda K; Jones PG; Cohen DJ; Zhao Z; Spertus JA; Smolderen KG
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions.
    Koskinas KC; Ndrepepa G; Räber L; Karagiannis A; Kufner S; Zanchin T; Hieber J; Hunziker L; Mayer K; Byrne RA; Heg D; Windecker S; Kastrati A
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e006752. PubMed ID: 30545257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
    Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive loading dose of cilostazol in preventing periprocedural myocardial infarction.
    Xu LX; Chen KY; Liu T; Zheng XT; Jiao ZQ; Xu Y; Li G
    Cardiovasc Ther; 2016 Aug; 34(4):225-33. PubMed ID: 27133311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI.
    Wang HY; Xu B; Dou K; Guan C; Song L; Huang Y; Zhang R; Xie L; Zhang M; Yan H; Yang W; Wu Y; Yang Y; Qiao S; Gao R; Stone GW
    JACC Cardiovasc Interv; 2021 Aug; 14(15):1623-1634. PubMed ID: 34353593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stents.
    Tandjung K; Basalus MW; Muurman E; Louwerenburg HW; van Houwelingen KG; Stoel MG; de Man FH; Jansen H; Huisman J; Linssen GC; Droste HT; Nienhuis MB; von Birgelen C
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):524-30. PubMed ID: 22109857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Kume K; Yasuoka Y; Adachi H; Noda Y; Hattori S; Araki R; Kohama Y; Imanaka T; Matsutera R; Kosugi M; Sasaki T
    Cardiovasc Revasc Med; 2013; 14(5):253-7. PubMed ID: 23993293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
    Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.
    Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C
    Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary percutaneous coronary intervention without on-site cardiac surgery backup in unselected patients with ST-segment-elevation myocardial infarction: the Rivoli ST-segment elevation myocardial infarction (RISTEMI) registry.
    Tomassini F; Gagnor A; Montali N; Infantino V; Tizzani E; Tizzani P; Lanza GA; Conte MR; Varbella F
    Cardiovasc Revasc Med; 2013; 14(1):9-13. PubMed ID: 23337379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction.
    Toso A; Leoncini M; Maioli M; Gallopin M; Tedeschi D; Amato M; Bellandi F
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):318-21. PubMed ID: 21045713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of baseline C-reactive protein for periprocedural myocardial infraction of higher risk stratifications: A retrospective cohort clinical study.
    Yao M; Zhao L; Wu L; Zhang W; Luan Y; Song J; Fu G; Zhu J
    Anatol J Cardiol; 2018 Dec; 20(6):310-317. PubMed ID: 30297597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.